Organic Cation Transporter 1 Inhibitors [MoA] class drugs

4 results
  • vonjo - pacritinib capsule

    (Pacritinib)
    Sobi, Inc.
    Vonjo treats adults with intermediate or high-risk primary or secondary myelofibrosis (post-polycythemia vera or post-essential thrombocythemia) with a platelet count below 50 × 10⁹/L. Approved under accelerated approval based on spleen volume reduction.
  • xalkori - crizotinib capsule

    (Crizotinib)
    Pfizer Laboratories Div Pfizer Inc
    XALKORI treats adults with ALK- or ROS1-positive metastatic non-small cell lung cancer; patients 1 year and older with relapsed or refractory ALK-positive anaplastic large cell lymphoma; and patients 1 year and older with unresectable, recurrent, or refractory ALK-positive inflammatory myofibroblastic tumor.